Stocks
Aytu BioPharma, Inc.AYTU
NASDAQHealthcareBiotechnology$1.90
Price as of · delayed, not real-time
A specialty pharmaceutical company focused on commercializing products for the urology and gastroenterology markets, with a portfolio that includes treatments for overactive bladder and other niche conditions. Investors track Aytu BioPharma for its revenue growth from recently launched products and its strategy to expand through acquisitions and partnerships.
52W Range: $1.80-$3.07
Congressional Interest in Aytu BioPharma, Inc. (AYTU)
1 member of Congress has disclosed 1 trade in Aytu BioPharma, Inc. (AYTU), a Healthcare company. The buy/sell breakdown shows 1 purchase versus 0 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
1
Unique Politicians
1
Buys
1
Sells
0
Who in Congress Is Trading AYTU?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2015-11-02 | Jared Polis | buy | $1K-$15K |